ArticleJournal of radiation research2025
Independent verification system for intracavitary brachytherapy based on a reference plan and statistical model.
Article in Journal of radiation research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
High dose rate (HDR) intracavitary brachytherapy (ICBT) with a remote afterloading system plays a vital role in the treatment of cervical cancer. We aimed to develop a new verification system for ICBT for cervical cancer and evaluate the feasibility for clinical plans (PlanClin) generated for different remote afterloaders, applicators and treatment techniques. In total, 517 PlansClin of patients were treated with Elekta 192Ir microSelectron HDR v2r. Reference plans (PlanRef) were generated for the ICBT applicators. An equation to predict total dwell time (Tdwell) of PlanClin was generated by evaluating the relationship between the volume receiving 100% of the prescribed dose (V100%) and the Tdwell. We also developed software to detect human errors in PlanClin by comparing parameters, including applicator and reference point geometries, dwell position and weight patterns and reference point dose, with those of PlanRef. Feasibility was evaluated for 83 PlanClin cases treated with the Elekta Flexitron remote afterloader and six ICBT plans with extra catheters (hybrid BT). The linear fitting function showed good agreement with the correlation between V100% and Tdwell. The developed equation accurately estimated the Tdwell of the PlanClin treated with the Flexitron with an accuracy of 0.26 ± 0.49%. Our system successfully detected intentional human errors including incorrect channel mapping, applicator tip offset, incorrect plan templates, an applicator digitization model and incorrect reference points. A verification system based on PlanRef and a statistical approach is feasible for the new remote afterloaders, applicators and hybrid BT techniques. This system contributes to the implementation of safe treatments.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.